• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Editor's Pick Nestle to launch frozen pizzas, other foods targeting users of weight-loss drugs
Editor's Pick

Nestle to launch frozen pizzas, other foods targeting users of weight-loss drugs

by May 22, 2024
by May 22, 2024 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing market of consumers who are using GLP-1 drugs like Ozempic and Wegovy.

Over the last year, the buzzy weight loss and diabetes drugs have taken off as more options hit the market and celebrities like Oprah Winfrey and Elon Musk endorse them. Roughly 1 in 8 adults in the U.S. has used a GLP-1 drug at some point, according to a recent survey from the health policy research organization KFF. Roughly half of those Americans, or around 6% of U.S. adults, are currently using one of the treatments. The total number of U.S. consumers taking the medication could soar to 31.5 million, or 9% of the total population, by 2035, according to Morgan Stanley research.

As the drugs’ popularity has soared, investors have grown concerned about what their rise means for food and beverage companies and fast-food chains. People who take the medication typically eat less frequently because they have fewer cravings and desire more protein and less sugary and fatty foods. In October, Walmart’s U.S. CEO John Furner told Bloomberg that people who pick up GLP-1 drugs from its pharmacies are buying less food, typically with fewer calories.

But Nestle sees an opportunity to cater to those consumers through Vital Pursuit.

“The reality is, for the last 25 years, the diet has been dying, in a sense. … For me, what we’ve done is actually given consumers a new tool that actually gives them confidence and success on this journey,” Nestle’s North America CEO Steve Presley told CNBC.

The new brand’s initial lineup of 12 items will include frozen bowls with whole grains or protein-packed pasta, along with sandwich melts and pizzas. The products will include one or more essential nutrients, like protein, calcium or iron. The company plans to sell Vital Pursuit items for $4.99 or under and offer gluten-free options.

Vital Pursuit’s packaging won’t include mentions of GLP-1 medications, but Nestle said the company will more directly connect the brand to the drugs on social media.

The new line will hit the freezer aisle by the fourth quarter.

In recent years, Nestle has also tried to focus more on health-conscious consumers. In 2018, it sold its U.S. candy business, which includes brands like Butterfinger, Crunch and Laffy Taffy, to Ferrero for $2.8 billion. Nestle’s food business, which includes brands like Stouffer’s and Toll House, only accounts for 14.5% of its U.S. sales.

Nestle already owns Lean Cuisine, which was founded in 1981 as a healthier alternative to other frozen meals. But the company chose to create a new brand to reach GLP-1 users because Lean’s branding focuses on consumers looking to limit their calories. But people who take GLP-1 medications may want to consume more nutrients, like protein, which can help with the muscle loss associated with the drugs. 

“The consumer research shows that there are certain nutrients and certain macros that need to be delivered to actually help the consumers stay healthy along the journey of the GLP-1 treatment,” Presley said.

Shares of Swiss-based Nestle have fallen 16% this year, dragging its market value down to $278 billion. The food company expects that its global growth will slow this year as inflation-weary consumers buy less of its products.

This post appeared first on NBC NEWS
You Might Also Like
  • UAW autoworkers officially ratified new contract, union says
  • Boeing’s new outsider CEO Ortberg takes the helm, this time from the factory floor
  • Gold bars are selling like hot cakes in Korea’s convenience stores and vending machines
  • Disneyland characters and parades cast members launch unionization effort
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Hims & Hers Health says it will offer compounded GLP-1 injections
next post
Supreme Court Justice Samuel Alito sold Bud Light owner’s stock amid boycott

You may also like

Universal’s new Epic Universe park set to generate $2 billion...

April 16, 2025

Welcome to the housing market’s ‘new normal’ — 7% mortgage...

February 26, 2024

Torch Introduces Low-Cost Comprehensive IoT and AI Solution for Early-Stage...

March 15, 2023

SEC charges Carl Icahn with hiding billions of dollars worth...

August 20, 2024

Autoworkers go on strike at plants for each of the...

September 15, 2023

A year after Silicon Valley Bank failed, another regional lender...

March 2, 2024

First Republic bank says deposits tumbled 40% to $104.5 billion...

April 26, 2023

How to Significantly Reduce Development Cost and Timeframe with the...

January 17, 2023

FDA declares cucumber-linked Salmonella outbreak over after 155 hospitalized

August 26, 2024

Netflix shares soar as company reports surging revenue, tops 300...

January 22, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Week Ahead: As NIFTY Breaks Out, Change Of Leadership Likely To Keep The Index Moving

      June 28, 2025
    • 3 Stock Setups for the Second Half of 2025

      June 28, 2025
    • Fibonacci Retracements: The Key to Identifying True Breakouts

      June 27, 2025
    • All-Time Highs and An Upcoming Rate Cut: We’re Just Getting Started on This Move Higher

      June 27, 2025
    • How to Improve your Trading Odds and Increase Opportunities

      June 27, 2025

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 3,615 views
    • 2

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,895 views
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,588 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,551 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,429 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,151)
    • Investing (538)
    • Stock (2,640)

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Week Ahead: As NIFTY Breaks Out, Change Of Leadership Likely...

      June 28, 2025
    • 3 Stock Setups for the Second Half of 2025

      June 28, 2025
    • Fibonacci Retracements: The Key to Identifying True Breakouts

      June 27, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,151)
    • Investing (538)
    • Stock (2,640)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    ‘Shark Tank’ alum Bombas taps former...

    May 16, 2025

    Caitlin Clark’s pro salary exposes an...

    April 22, 2024

    Judge blocks JetBlue-Spirit merger in a...

    January 17, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here